SE8704248D0 - MEDICAL USE - Google Patents

MEDICAL USE

Info

Publication number
SE8704248D0
SE8704248D0 SE8704248A SE8704248A SE8704248D0 SE 8704248 D0 SE8704248 D0 SE 8704248D0 SE 8704248 A SE8704248 A SE 8704248A SE 8704248 A SE8704248 A SE 8704248A SE 8704248 D0 SE8704248 D0 SE 8704248D0
Authority
SE
Sweden
Prior art keywords
bone
loss
diseases
medical use
hypercalcinemia
Prior art date
Application number
SE8704248A
Other languages
Swedish (sv)
Inventor
I Starke
B Wallmark
K Veenenen
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Priority to SE8704248A priority Critical patent/SE8704248D0/en
Publication of SE8704248D0 publication Critical patent/SE8704248D0/en
Priority to EP88909620A priority patent/EP0339071A1/en
Priority to PCT/SE1988/000576 priority patent/WO1989003833A1/en
Priority to KR1019890701209A priority patent/KR890701587A/en
Priority to JP63508894A priority patent/JPH02501929A/en
Priority to AU26203/88A priority patent/AU2620388A/en
Priority to HU886708A priority patent/HU203663B/en
Priority to IL88205A priority patent/IL88205A0/en
Priority to DK322189A priority patent/DK322189D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for the treatment of diseases related to loss of bone mass such as osteoporosis, Paget's disease of bone, hyperparathyroidism, malignant neoplasms causing hypercalcinemia, parodontal diseases and implant-related bone loss comprising administration to a patient suffering therefrom an amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
SE8704248A 1987-10-30 1987-10-30 MEDICAL USE SE8704248D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE8704248A SE8704248D0 (en) 1987-10-30 1987-10-30 MEDICAL USE
EP88909620A EP0339071A1 (en) 1987-10-30 1988-10-27 IMIDAZO(1,2-a)(PYRIDAZINES OR PYRAZINES) FOR TREATMENT OF DISEASES RELATED TO BONE LOSS
PCT/SE1988/000576 WO1989003833A1 (en) 1987-10-30 1988-10-27 IMIDAZO(1,2-a)(PYRIDAZINES OR PYRAZINES) FOR TREATMENT OF DISEASES RELATED TO BONE LOSS
KR1019890701209A KR890701587A (en) 1987-10-30 1988-10-27 Imidazo (1,2-a) for treating diseases related to bone loss
JP63508894A JPH02501929A (en) 1987-10-30 1988-10-27 medical use
AU26203/88A AU2620388A (en) 1987-10-30 1988-10-27 Imidazo(1,2-a)(pyridazines or pyrazines) for treatment of diseases related to bone loss
HU886708A HU203663B (en) 1987-10-30 1988-10-27 Process for producing pharmaceutical composition against osteoporosis containing imidazo(1,2)pyridine derivatives
IL88205A IL88205A0 (en) 1987-10-30 1988-10-28 Novel pyridine compounds and compositions for the treatment of osteoporosis
DK322189A DK322189D0 (en) 1987-10-30 1989-06-28 IMIDAZO (1,2-A) - (PYRIDAZINES OR PYRAZINES) FOR THE TREATMENT OF DISEASES WITH RELATIONSHIP TO BONE LOSS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704248A SE8704248D0 (en) 1987-10-30 1987-10-30 MEDICAL USE

Publications (1)

Publication Number Publication Date
SE8704248D0 true SE8704248D0 (en) 1987-10-30

Family

ID=20370069

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704248A SE8704248D0 (en) 1987-10-30 1987-10-30 MEDICAL USE

Country Status (9)

Country Link
EP (1) EP0339071A1 (en)
JP (1) JPH02501929A (en)
KR (1) KR890701587A (en)
AU (1) AU2620388A (en)
DK (1) DK322189D0 (en)
HU (1) HU203663B (en)
IL (1) IL88205A0 (en)
SE (1) SE8704248D0 (en)
WO (1) WO1989003833A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87988B (en) * 1987-07-16 1995-05-04 Byk Gulden Lomberg Chem Fab PROCESS FOR THE PREPARATION OF DIAZOIS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
US5081253A (en) * 1989-12-21 1992-01-14 American Home Products Corporation Imidazo(4,5-c)pyridines as antiosteoporotic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
AU5348396A (en) * 1995-05-01 1996-11-21 Fujisawa Pharmaceutical Co., Ltd. Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivati ves and their use as bone resorption inhibitors
GB9518552D0 (en) * 1995-09-11 1995-11-08 Fujisawa Pharmaceutical Co New heterocyclic compounds
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
EP2655362A1 (en) 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
DE102012200349A1 (en) 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituted fused pyrimidines and triazines and their use
US8778964B2 (en) 2012-11-05 2014-07-15 Bayer Pharma Aktiengesellschaft Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
US9624214B2 (en) 2012-11-05 2017-04-18 Bayer Pharma Aktiengesellschaft Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US8796305B2 (en) 2012-11-05 2014-08-05 Bayer Pharma Aktiengesellschaft Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
US9126998B2 (en) 2012-11-05 2015-09-08 Bayer Pharma AG Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
CN105339368B (en) 2013-06-04 2017-08-15 拜耳制药股份公司 Imidazo [1,2 a] pyridine of 3 aryl substitution and application thereof
WO2015004105A1 (en) 2013-07-10 2015-01-15 Bayer Pharma Aktiengesellschaft Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
CN106459090A (en) 2014-02-19 2017-02-22 拜耳制药股份公司 3-(pyrimidine-2-yl)imidazo[1,2-A]pyridines
EP3119777A1 (en) 2014-03-21 2017-01-25 Bayer Pharma Aktiengesellschaft Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
CA2947372A1 (en) * 2014-05-02 2015-11-05 Bayer Pharma Aktiengesellschaft 6-chlorine-substituted imidazo[1,2-a]pyridine carboxamides and the use thereof as soluble guanylate cyclase stimulators
US20170050962A1 (en) * 2014-05-02 2017-02-23 Bayer Pharma Aktiengesellschaft Imidazo[1,2-a]pyridines as stimulators of soluble guanylate cyclase for treating cardiovascular diseases
WO2015165930A1 (en) 2014-05-02 2015-11-05 Bayer Pharma Aktiengesellschaft Enantiomers of the n-(2-amino-5-fluoro-2-methylpentyl)-8-[(2,6-difluorobenzyl)oxy]-2-methylimidazo[1,2-a]pyridine-3-carboxamide, as well as of the di- and trifluoro derivatives for the treatment of cardiovascular diseases
WO2016087343A1 (en) 2014-12-02 2016-06-09 Bayer Pharma Aktiengesellschaft Heteroaryl-substituted imidazo[1,2-a]pyridines and their use
WO2016087342A1 (en) 2014-12-02 2016-06-09 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines and their use
EP3286185A1 (en) 2015-02-05 2018-02-28 Bayer Pharma Aktiengesellschaft Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
WO2016124564A1 (en) 2015-02-05 2016-08-11 Bayer Pharma Aktiengesellschaft N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6-dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cylase (sgc) for the treatment of cardiovascular diseases
WO2018184976A1 (en) 2017-04-05 2018-10-11 Bayer Pharma Aktiengesellschaft Substituted imidazo[1,2-a]pyridinecarboxamides and use of same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
DE3446778A1 (en) * 1984-12-21 1986-07-03 Dr. Karl Thomae Gmbh, 7950 Biberach NEW IMIDAZO DERIVATIVES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
DK322189A (en) 1989-06-28
HUT51138A (en) 1990-04-28
WO1989003833A1 (en) 1989-05-05
HU203663B (en) 1991-09-30
JPH02501929A (en) 1990-06-28
AU2620388A (en) 1989-05-23
EP0339071A1 (en) 1989-11-02
KR890701587A (en) 1989-12-21
IL88205A0 (en) 1989-06-30
DK322189D0 (en) 1989-06-28

Similar Documents

Publication Publication Date Title
SE8704248D0 (en) MEDICAL USE
ES555147A0 (en) A PROCEDURE FOR THE PRODUCTION OF A HYPOGLYCEMIC THIAZOLIDINDIONA COMPOUND
ITFI910071U1 (en) BONE PLATE FOR THE DISTAL PORTION OF THE HUMERUS.
EP0395441A3 (en) Treating agent for osteoarthritis
ES2052028T3 (en) A METHOD FOR PREPARING ANTI-ATEROSCLEROTIC DIARILIC COMPOUNDS.
IL82084A0 (en) 1,4-diazepines,their preparation and pharmaceutical compositions containing them
IT1238825B (en) DEVICE FOR SURGICAL CORRECTION OF AMETROPIA.
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
IT9041503A0 (en) DEVICE FOR THE SURGICAL TREATMENT OF AMETROPIA
EP0269311A3 (en) Methods of treating bone diseases by administration of a cysteine proteinase inhibitor
SE8903529D0 (en) MEDICAL USE
ZA863382B (en) Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs
SE8704436D0 (en) USE OF ANTI-SECRETARY SUBSTANCES FOR NEW INDICATIONS
DE69501359D1 (en) Use of phosphate diesters for the treatment of diseases of the retina
HUT42770A (en) Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same
SE9402001D0 (en) Pyridyl bisphosphonates for use as a therapeutic agent
PT99864A (en) METHOD FOR PREPARING NEW PHARMACEUTICAL COMPOSITIONS CONTAINING QUISQUALATE RECEPTOR ANTAGONISTS
IT8219482A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ORAL CAVITY DISEASES.
DE69007065D1 (en) Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases.
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
GR861013B (en) Process for the preparation of triazole derivatives
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
ATE147978T1 (en) USE OF (E)-2-(P-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
IL101163A (en) Use of flunarizine in the preparation of medicaments for treating neoplastic diseases
EP0358438A3 (en) Ethanesulfonamide derivatives